Download this White Paper
Even though nucleic acid therapeutics have been around for fifty years, advances in molecular biology have led to the emergence of a major new class of medicines with almost limitless potential to treat common and rare diseases. Download now to learn how the UK's leading science and innovation campus has evolved to become the UK hub for nucleic acid therapy research.
Key takeaways from this whitepaper include:
Offered Free by: Harwell
See All Resources from: Harwell